Literature DB >> 3023888

Characterization of G1 transit induced by the mitogenic-oncogenic viral Ki-ras gene product.

J P Durkin, J F Whitfield.   

Abstract

NRK rat kidney cells infected with a temperature-sensitive mutant of the Kirsten sarcoma virus (ts371) were transformed at 36 degrees C but were phenotypically nontransformed at 41 degrees C because of the abnormal thermolability of the oncogenic 21-kilodalton product of the viral Ki-ras gene. Thus tsK-NRK cells were rendered quiescent in a G0-G1 state by a 48-h incubation in serum-free medium at the nonpermissive, p21-inactivating temperature of 41 degrees C. The serum-starved cells could then be stimulated to transit G1 either as nontransformed cells by adding serum at 41 degrees C or as transformed cells by lowering the temperature to a p21-activating 36 degrees C. The viral p21 protein was as effective as serum in stimulating tsK-NRK cells to transit G1 and to start replicating DNA. While p21 effectively stimulated cells to transit G1 even in unconditioned, serum-free medium, they still needed cell-derived conditioning factors to subsequently divide. The p21 protein also enabled the cells to transit G1 in spite of an extracellular Ca2+ deficiency that inhibited the G1 transit of serum-stimulated cells. p21 activity was needed to stimulate both early and late G1 events. In contrast to serum, p21 did not stimulate total RNA or protein synthesis, but some RNA and protein synthesis must have been needed for the p21-driven G1 transit because it could be stopped by actinomycin D or cycloheximide.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023888      PMCID: PMC367662          DOI: 10.1128/mcb.6.5.1386-1392.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Different extracellular calcium requirements for proliferation of nonneoplastic, preneoplastic, and neoplastic mouse cells.

Authors:  A L Boynton; J F Whitfield; R J Isaacs; R G Tremblay
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

3.  Continuous protein synthesis is required to maintain the probability of entry into S phase.

Authors:  R F Brooks
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

4.  The roles of calcium and cyclic AMP in the stimulatory action of parathyroid hormone on thymic lymphocyte proliferation.

Authors:  J F Whitfield; J P MacManus; T Youdale; D J Franks
Journal:  J Cell Physiol       Date:  1971-12       Impact factor: 6.384

5.  Protein degradation in cultured cells. The effect of fresh medium, fluoride, and iodoacetate on the digestion of cellular protein of rat fibroblasts.

Authors:  B Poole; M Wibo
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

6.  Control of translation in cultured cells: continued synthesis and accumulation of messenger RNA in nondividing cultures.

Authors:  P S Rudland
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

7.  The initiation of cell division in a contact-inhibited mammalian cell line.

Authors:  G J Todaro; G K Lazar; H Green
Journal:  J Cell Physiol       Date:  1965-12       Impact factor: 6.384

8.  p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation.

Authors:  T Y Shih; M O Weeks; H A Young; E M Scolnick
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  The mitogenic/oncogenic p21 Ki-RAS protein stimulates adenylate cyclase activity early in the G1 phase of NRK rat kidney cells.

Authors:  D J Franks; J F Whitfield; J P Durkin
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

Review 10.  Regulation of proliferation of normal and neoplastic rat liver cells by calcium and cyclic AMP.

Authors:  S H Swierenga; J F Whitfield; A L Boynton; J P MacManus; R H Rixon; M Sikorska; B K Tsang; P R Walker
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

View more
  10 in total

Review 1.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

3.  Ras binding triggers ubiquitination of the Ras exchange factor Ras-GRF2.

Authors:  C L de Hoog; J A Koehler; M D Goldstein; P Taylor; D Figeys; M F Moran
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  The viral Ki-ras gene must be expressed in the G2 phase if ts Kirsten sarcoma virus-infected NRK cells are to proliferate in serum-free medium.

Authors:  J P Durkin; J F Whitfield
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

5.  Functional specificity of ras isoforms: so similar but so different.

Authors:  Esther Castellano; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

Review 6.  The immuno-oncological challenge of COVID-19.

Authors:  Lisa Derosa; Cléa Melenotte; Franck Griscelli; Bertrand Gachot; Aurélien Marabelle; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Cancer       Date:  2020-10-02

7.  Ras activation of genes: Mob-1 as a model.

Authors:  P Liang; L Averboukh; W Zhu; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells.

Authors:  B Czerniak; F Herz; R P Wersto; L G Koss
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

9.  Coumarin modulates the cell-cycle progression of an MTV-EJras cell line.

Authors:  J Kahn; P Preis; F Waldman; A Tseng
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling.

Authors:  Hassan Mziaut; Georg Henniger; Katharina Ganss; Sebastian Hempel; Steffen Wolk; Johanna McChord; Kamal Chowdhury; Philippe Ravassard; Klaus-Peter Knoch; Christian Krautz; Jürgen Weitz; Robert Grützmann; Christian Pilarsky; Michele Solimena; Stephan Kersting
Journal:  Mol Metab       Date:  2019-11-22       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.